REFRACTORY LARGE B-CELL LYMPHOMA
Clinical trials for REFRACTORY LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New outpatient treatment trial offers hope for Tough-to-Treat lymphoma patients
Disease control Recruiting nowThis study is testing whether the drug epcoritamab can help control aggressive lymphoma that has returned or stopped responding to initial treatment. It's for patients who are not candidates for a stem cell transplant. Researchers will give the drug in an outpatient setting and m…
Matched conditions: REFRACTORY LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New CAR-T therapy trial offers hope for patients with aggressive lymphoma
Disease control Recruiting nowThis study is testing a new CAR-T cell therapy called TC011 for adults with aggressive B-cell lymphoma that has come back or hasn't responded to at least two prior treatments. The main goals are to find a safe dose and see if the therapy can shrink or eliminate tumors. It is for …
Matched conditions: REFRACTORY LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC